VLP-antigen conjugates and their uses as vaccines

Details for Australian Patent Application No. 2005291231 (hide)

Owner Cytos Biotechnology AG

Inventors Maurer, Patrik; Schwarz, Katrin; Meijerink, Edwin; Bachmann, Martin; Proba, Karl

Agent Watermark

Pub. Number AU-B-2005291231

PCT Pub. Number WO2006/037787

Priority 60/615,637 05.10.04 US; 05105228.0 14.06.05 EP

Filing date 5 October 2005

Wipo publication date 13 April 2006

Acceptance publication date 23 December 2010

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

Event Publications

3 May 2007 PCT application entered the National Phase

  PCT publication WO2006/037787 Priority application(s): WO2006/037787

23 December 2010 Application Accepted

  Published as AU-B-2005291231

21 April 2011 Standard Patent Sealed

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005291233-A pharmaceutical formulation comprising crystalline insulin and dissolved insulin

2005291226-Integrated process for hydrocarbon synthesis